Home Urban Health Today Conference Coverage

Conference Coverage

Evaluating Pirtobrutinib in Patients with Previously Treated Mantle Cell Lymphoma

Evaluating Fixed-Duration Ibrutinib and Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia

Rituximab, Bendamustine, and Bortezomib Combination Improves Responses in Relapsed/Refractory Waldenström Macroglobulinemia

Belantamab Mafodotin Shows ‘Encouraging Results’ in Patients with Relapsed/Refractory Multiple Myeloma

Orelabrutinib Shows Favorable Safety and Efficacy in Relapsed/Refractory Waldenström Macroglobulinemia

GLOW: MRD Outcomes After Fixed-Duration Ibrutinib Combinations in Older CLL Patients

iStopMM: Screening for MGUS Enables Earlier Detection and Intervention

Long-Term Follow-up From GRIFFIN Confirms Durability of Daratumumab Responses in Transplant-Eligible Myeloma

Study Validates IMWG Frailty Scoring in Relapsed/Refractory Multiple Myeloma

Ibrutinib Plus FCR Could Provide Functional Cure in Young CLL Patients

Load more
Subscribe to RSS